AI주식인사이트AI Stock Insight
C

퀀타매트릭스

317690KOSDAQ의료용 기기 제조업

52.5 / 100

Reference Date: 2026-04-13

Financial Score18.0 / 40
News Sentiment17.5 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly down 1.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Quantametrics is a company specializing in the development, production, and sale of in-vitro diagnostics (IVD) medical devices, focusing on early diagnosis and prognosis prediction for sepsis and antimicrobial susceptibility testing (AST). The company leverages innovative technologies such as microfluidic chips and agarose gel to provide high-sensitivity and high-accuracy diagnostic solutions to hospitals and testing institutions.

Number of Employees

103people

Average Salary

54.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 26.524.0Point
PBR
1.88Industry Average 1.702.5Point

Higher than industry avg (caution)

ROE
-83.64Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
3.50Industry Average 10.956.5Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲13.9% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲15.9% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -107.2% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 70

Detailed Momentum

52-week position3.0Point

52w lower range (29%)

Current 3,745Won52-week high 5,67052-week low 2,940
1-month return3.0Point

1m -1.71% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-04-01
  • Neutral정기주주총회결과2026-03-31
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
  • Neutral감사보고서제출2026-03-23
  • Neutral사업보고서 (2025.12)2026-03-23